Odyssey Therapeutics, Inc. ODTX Income Statement
| Q1 '26 | ||
|---|---|---|
| $0-100% | ||
| $32.32M-16.6% | ||
| $7.35M-7.6% | ||
| $39.78M-3.2% | ||
| -$39.78M-1.6% | ||
| $10K+400% | ||
| $1.58M+82.8% | ||
| -$38.2M+0.3% | ||
| $63K-55.0% | ||
| -$38.26M+0.5% | ||
| -$6.77+82.8% | ||
| -$38.61M-2.0% | ||
| -$39.78M-1.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Odyssey Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Odyssey Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.